(Q36376519)

13 August 2017

1 reference

title

Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? (English)

1 reference

chronic obstructive pulmonary disease

13 August 2017

0 references

1 reference

Beeh KM

1

1 reference

13 August 2017

Beier J

series ordinal

2

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Clinical & Experimental Allergy

13 August 2017

published in

1 reference

13 August 2017

volume

36

1 reference

13 August 2017

issue

2

1 reference

13 August 2017

page(s)

142-157

1 reference

Neutrophils and the pathogenesis of COPD.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The cellular composition of induced sputum in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Ongoing airway inflammation in patients with COPD who do not currently smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophils and protease/antiprotease imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Integrin upregulation on sputum neutrophils in smokers with chronic airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Enhanced neutrophil response in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The interrelationship of sputum inflammatory markers in patients with chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Increased glutathione disulfide and nitrosothiols in sputum supernatant of patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Characterization of the Integrin and Activation Steps Mediating Human Eosinophil and Neutrophil Adhesion to Chronically Inflamed Airway Endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Chemokines: leucocyte recruitment and activation cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Myeloperoxidase: friend and foe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Matrix metalloproteinase-9 in lung remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophilic infiltration within the airway smooth muscle in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The trials and tribulations of IL-5, eosinophils, and allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Is the neutrophil the key effector cell in severe asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Steroid resistance in asthma. Molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Increased levels of airway neutrophils reduce the inhibitory effects of inhaled glucocorticosteroids on allergen-induced airway eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Characterization of the neutrophil respiratory burst in atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Production of oxygen radicals by peripheral blood neutrophils is increased in patients with stable asthma and during exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Enhancement of Antigen-specific functional responses by neutrophils from allergic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Decreased intercellular adhesion molecule-1 (CD54) and L-selectin (CD62L) expression on peripheral blood natural killer cells in asthmatic children with acute exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Airways inflammation and COPD: epithelial-neutrophil interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

E- and P-selectins are essential for the development of cockroach allergen-induced airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

A selectin inhibitor decreases neutrophil infiltration during acute Mannheimia haemolytica pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Novel synthetic inhibitors of selectin-mediated cell adhesion: synthesis of 1,6-bis[3-(3-carboxymethylphenyl)-4-(2-alpha-D- mannopyranosyloxy)phenyl]hexane (TBC1269).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Inhibition of adhesion of human neutrophils and eosinophils to P-selectin by the sialyl Lewis antagonist TBC1269: preferential activity against neutrophil adhesion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effect of a single dose of the selectin inhibitor TBC1269 on early and late asthmatic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophil elastase inhibitors as treatment for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Recombinant alpha 1-proteinase inhibitor blocks antigen- and mediator-induced airway responses in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Airway remodeling and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

New indications for treatment of chronic inflammation by TNF-alpha blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Dose-dependent cigarette smoking-related inflammatory responses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

First study of infliximab treatment in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Phosphodiesterase 4 inhibitors for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effect of cilomilast (Ariflo) on TNF-alpha, IL-8, and GM-CSF release by airway cells of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The new phosphodiesterase 4 inhibitor roflumilast is efficacious in exercise-induced asthma and leads to suppression of LPS-stimulated TNF-alpha ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The effects of macrolides on inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Macrolides in the treatment of asthma and cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Oxidative stress in allergic respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

The influence of age on induced sputum differential cell counts in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Platinum-Based, Leukocyte-Depleting Chemotherapy Does Not Alter Induced Sputum Markers of Neutrophilic Inflammation in COPD Patients with Unresectable Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Epithelial Permeability, Inflammation, and Oxidant Stress in the Air Spaces of Smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophil Retention in the Lungs of Patients with Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.2006.02418.X

10.1111/J.1365-2222.2006.02418.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference